Barrett & Company’s Esperion Therapeutics ESPR Stock Holding History

Barrett & Company’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-300	Closed	-$295	–	647
2025 Q2	$295	Hold	300	–	–	﹤0.01%	628
2025 Q1	$432	Hold	300	–	–	﹤0.01%	605
2024 Q4	$660	Hold	300	–	–	﹤0.01%	590
2024 Q3	$495	Hold	300	–	–	﹤0.01%	564
2024 Q2	$666	Hold	300	–	–	﹤0.01%	573
2024 Q1	$804	Hold	300	–	–	﹤0.01%	583
2023 Q4	$897	Hold	300	–	–	﹤0.01%	572
2023 Q3	$294	Hold	300	–	–	﹤0.01%	608
2023 Q2	$417	Hold	300	–	–	﹤0.01%	584
2023 Q1	$477	Hold	300	–	–	﹤0.01%	566
2022 Q4	$1.87K	Hold	300	–	–	﹤0.01%	519
2022 Q3	$1.87K	Buy	+300	New	+$2.06K	﹤0.01%	519

Other funds holding ESPR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return